UK Research and Innovation: Ethnic Minorities

Debate between Baroness Royall of Blaisdon and Lord Vallance of Balham

Monday 15th December 2025 Lords Chamber

[Lord Vallance of Balham (Lab)]

I think the noble Lord may be referring to the scheme run by the Laboratory of Molecular Biology, which is one of the world’s greatest research institutions, with 12 Nobel Prizes to its name. It has rightly taken two posts out of 128 specifically to increase black representation among scientists. This is very similar to what happened in 1995, when the Dorothy Hodgkin fellowships made positions for women more easily accessible; that led to a huge number of very successful women scientists emerging as a result of that. In terms of the research excellence framework, there is an increased weighting for research outputs, which I believe to be correct. There is, however, a significant weighting on strategy, people and research environment. A culture where bullying is tolerated, challenge is suppressed and diversity is not embraced is not conducive to great science.

[Baroness Royall of Blaisdon (Lab)]

My Lords, does my noble friend the Minister agree with the multiple analyses of major funders, including UKRI and the US National Science Foundation, which have consistently found that white applicants have higher grant awards than ethnic minority researchers? Indeed, in 2020-21, UKRI PI awardees were 81% white and 1% black. The major reason, I suggest, is that black, Asian and other minority ethnicities are underrepresented in academia; we have just 160 black professors, of whom only a quarter are women. Does the Minister agree that efforts to address these stark inequalities should be welcomed rather than criticised?

[Lord Vallance of Balham (Lab)]

Just to add to the starkness of those numbers, it is 160 black professors out of 22,885 professors overall. These are stark figures, and we need to do things to make sure that we get opportunity right. Yes, the figures are also stark for grants. It is interesting that the analysis of schemes that have been put in place already shows that, as a result of those schemes, not only does confidence increase for black scientists but the preparedness and quality of their applications also increase.

Science and Innovation: Alan Turing Institute

Debate between Baroness Royall of Blaisdon and Lord Vallance of Balham

Monday 19th May 2025 Lords Chamber

[Lord Vallance of Balham (Lab)]

My noble friend is quite right that clinical trials are of huge importance and benefit healthcare just from the very fact that they take place in the healthcare system, irrespective of their outcome. Historically, we have been extremely good at clinical trials in this country. Indeed, during Covid, the world’s most important clinical trial took place here: the recovery study, which was the biggest, fastest and most important study and gave definitive results. However, it is also true that our performance in commercial clinical trials has deteriorated over the past few years. We are absolutely determined to return that to where it should be, and we will be clear in a very public way about the metrics and our progress against those, to make sure that we get back to where we belong.

[Baroness Royall of Blaisdon (Lab)]

My Lords, I remind noble Lords of my interests in the register. My noble friend the Minister is the Oxford-Cambridge innovation champion, to ensure the success of this economic engine for the country as a whole. Would he agree, however, that, in addition to the brilliant research and innovation from our universities and other institutions, it is necessary to bring local, regional and national government together to support the necessary infrastructure and investment, and the skills base? Would he further agree that it is vital to make all such developments inclusive, so that nobody is left behind and the people of the local communities can benefit from it?

[Lord Vallance of Balham (Lab)]

I thank the noble Baroness. I wonder whether she read the piece I wrote, which said something very similar. I agree entirely that this has to be inclusive innovation and that it is not about two shiny objects at the end of the line—Oxford and Cambridge—but about the corridor in its entirety. It absolutely needs to involve all the local partners in making this happen. At the end of it, it needs to improve opportunities and the economics for everybody.